Gateway Awards for New Investigators in Type 1 Diabetes Research (R03, no clinical trials)
This R03 Gateway Award funds New and Early Stage Investigators to conduct preliminary basic, translational, or clinical T1D research while embedded within established consortia (e.g., HIRN, TrialNet, TEDDY, DFC, CaRe-T1D). Projects must align with the scientific goals of one of the networks, cannot support clinical trials, and are intended to generate data and experience to prepare awardees fo…
Type 1 diabetes (T1D) is an autoimmune disease that destroys insulin-producing cells in the pancreas. The loss of proper glucose control that ensues leads to a variety of pathologic consequences, including complications affecting the heart, eye, nerves, kidney and urogenital systems. While the i…
Funding Source
Awards & funding
Eligibility
Foreign/Non-domestic eligibility: Non-domestic (non-U.S.) Entities (Foreign Organizations) are NOT eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are NOT eligible to apply. However, foreign components (as defined in the NIH Grants Policy Statement) are allowed within…
Dates
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers